Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen

Antibody-drug conjugates (ADC), combining the specificity of tumor recognition by monoclonal antibodies (mAb) and the powerful cytotoxicity of anticancer drugs, are currently under growing interest and development. Here, we studied the potential of Chi-Tn, a mAb directed to a glyco-peptidic tumor-as...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Sedlik, Christine, Heitzmann, Adèle, Viel, Sophie, Ait Sarkouh, Rafik, Batisse, Cornélie, Schmidt, Frédéric, De La Rochere, Philippe, Amzallag, Nathalie, Osinaga, Eduardo, Oppezzo, Pablo, Pritsch, Otto, Sastre-Garau, Xavier, Hubert, Pascale, Amigorena, Sebastian, Piaggio, Eliane
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2016
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006918/
https://ncbi.nlm.nih.gov/pubmed/27622021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1171434
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料